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Evolution of the EGFR pathway 
in Metazoa and its diversification 
in the planarian Schmidtea 
mediterranea
Sara Barberán1, José M. Martín-Durán2 & Francesc Cebrià1
The EGFR pathway is an essential signaling system in animals, whose core components are the 
epidermal growth factors (EGF ligands) and their trans-membrane tyrosine kinase receptors (EGFRs). 
Despite extensive knowledge in classical model organisms, little is known of the composition and 
function of the EGFR pathway in most animal lineages. Here, we have performed an extensive search 
for the presence of EGFRs and EGF ligands in representative species of most major animal clades, 
with special focus on the planarian Schmidtea mediterranea. With the exception of placozoans and 
cnidarians, we found that the EGFR pathway is potentially present in all other analyzed animal groups, 
and has experienced frequent independent expansions. We further characterized the expression 
domains of the EGFR/EGF identified in S. mediterranea, revealing a wide variety of patterns and 
localization in almost all planarian tissues. Finally, functional experiments suggest an interaction 
between one of the previously described receptors, Smed-egfr-5, and the newly found ligand Smed-
egf-6. Our findings provide the most comprehensive overview to date of the EGFR pathway, and 
indicate that the last common metazoan ancestor had an initial complement of one EGFR and one 
putative EGF ligand, which was often expanded or lost during animal evolution.
In multicellular organisms, communication between individual cells is essential for the regulation of complex bio-
logical processes, such as growth, differentiation, tissue renewal, and cell death. In animals, the receptor tyrosine 
kinases (RTKs) are well known mediators of intercellular signaling1,2. In particular, the epidermal growth factor 
receptor (EGFR) subfamily is the central constituent of a signaling pathway involved in multiple embryonic and 
adult processes3. For instance, it controls the fate and proliferation of multiple cell types in the invertebrate model 
systems Caenorhabditis elegans and Drosophila melanogaster4,5, and exerts a crucial function in the development 
and morphogenesis of many organs in vertebrate animals, such as the skin6, intestine7, the central nervous sys-
tem8 and mammary gland9, as well as in the progression of prevalent human diseases, such as cancers3.
Although constitutive and ligand-independent activations of the EGFR pathway have been described, espe-
cially in the context of several cancers10, EGFR signaling depends mainly on the binding of a peptide growth 
factor of the EGF-family to an EGFR. This interaction induces the phosphorylation of the cytoplasmic tyrosine 
kinase (TK) domain of the EGFR, and the subsequent activation of different intercellular transduction cascades 
that regulate downstream effector genes11. Despite slight differences, all identified EGFRs share conserved struc-
tural features that distinguish them from other RTKs. All consist of an extracellular ligand-binding domain con-
taining two or more cysteine rich clusters, a trans-membrane region, and a cytoplasmic domain with tyrosine 
kinase activity12. The nematode C. elegans and the fruit fly D. melanogaster have one single receptor (let-23 and 
der, respectively)13,14, but vertebrates have four EGFR classes: egfr (ErbB-1/her1), ErbB-2 (her2), ErbB-3 (her3) 
and ErbB-4 (her4)15. With respect to the ligands, all known EGF proteins are synthesized as transmembrane 
precursors characterized by the presence of an EGF-like domain (in some cases multiple EGF-like domains) in 
their extracellular region16. Cleavage of this membrane precursor in the extracellular milieu releases the active 
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EGF ligand, which contains a conserved cysteine-containing motif that confers binding specificity17. While C. 
elegans has only one ligand (lin-3)18, D. melanogaster has four (spitz, vein, gurken and keren)4,19, and vertebrates 
have an expanded set of 11 EGF ligands: the epidermal growth factor (egf), amphiregulin (areg), epigen, epiregulin 
(epr), betacellulin (btc), heparin-binding EGF-like growth factor (hb-egf), transforming growth factor-α (TGFα) and 
four neuregulins (nrg1-4)16,20,21. Notably, an additional extracellular immunoglobulin-like domain is present in 
the D. melanogaster ligand vein, and in the vertebrate ligands nrg1 and nrg2, which also contain an intracellular 
neuregulin domain21,22.
In recent years, research on the planarian flatworm Schmidtea mediterranea (Platyhelminthes)23–25 has 
clarified the role of the EGFR signaling pathway in the Spiralia (previously referred to as Lophotrochozoa26), 
which together with the Ecdysozoa (e.g. C. elegans and D. melanogaster) and the Deuterostomia (e.g. ver-
tebrates) form the three major groups of bilaterally symmetrical animals26. The planarian S. mediterranea is a 
well-established model in regenerative research, due to its striking ability to regrow any missing body part after 
injury27. Previous studies have identified four EGFRs in S. mediterranea (Smed-egfr-1, Smed-egfr-2, Smed-egfr-3 
and Smed-egfr-5), but only one representative in the related parasitic flatworm species Echinococcus multilocularis 
(EmER) and Schistosoma mansoni (SER)23,25,28,29. Additionally, one putative EGF ligand (Smed-epiregulin-1) and a 
neuregulin-like ligand (Smed-nrg-1) have been identified30,31. Interestingly, the planarian EGFRs and ligand show 
a broad spectrum of expression patterns23,25,30 and are functionally implicated in the regeneration and homeosta-
sis of different organs and cell types, such as the pharynx, the excretory and nervous systems, and the eye pigment 
cells23,25. Despite this progress in a member of the Spiralia, the presence, composition, and role of the EGFR path-
way in most animal lineages –apart from the classical developmental and biomedical model systems–, is virtually 
Clade Species
No. 
EGFR TM1 SP Cys rich Inactive TK
Ctenophora M. leidyi 1 1 Yes 3 No
Porifera A. queenslandica 1 1 ? 1 No
Placozoa T. adhaerens 0 – – – –
Cnidaria N. vectensis 0 – – – –
H. magnipapillata 0 – – – –
Xenacoelomorpha X. bocki 2 1(2)2 Yes 2(1), 3(1) No
M. stichopi 3 1(3) Yes 2(1), 3(1), 4(1) No
I. pulchra 5 1(4), ?(1) Yes(3), ?(2) 1(2), 3(2), ?(1) No
C. macropyga 3 1(3) Yes 4(2), 1(1) No
Priapulida P. caudatus 1 1 ? 3 No
H. spinulosus 1 1 Yes 3 No
Nematoda C. elegans 1 1 Yes 3 No
Arthropoda T. castaneum 1 1 Yes 2 No
D. melanogaster 1 1 Yes 3 No
Gastrotricha L. squamata 0 – – – –
Platyhelminthes M. lignano 8 1(6), ?(2) Yes(5), ?(3) 1(1), 2(2), 3(1), 4(1), ?(3) No
P. vittatus 6 1(6) Yes(5), ?(1) 2(2), 3(4) No
S. mediterranea 6 1(6) Yes(5), ?(1) 3(4), 4(2) No(5), Yes(1)
S. mansoni 3 1(3) Yes(1), ?(2) 3(1), 5(2) No
E. multilocularis 3 1(3) Yes(1), ?(2) 3(2), 4(1) No
Mollusca L. gigantea 2 1(1), ?(1) Yes(1), ?(1) 2(1), 3(1) No(1), Yes(1)
C. gigas 2 1(1), ?(1) ?(2) ? No
Annelida O. fusiformis 1 1 Yes 3 No
C. teleta 1 1 ? 3 No
H. robusta 6 1(4), ?(2) ?(6) 2(1), 3(1), 4(2), ?(2) No
Nemertea L. ruber 1 1 Yes 3 No
Bryozoa M. membranacea 3 1(2), 2(1) Yes(2), ?(1) 3 No
Brachiopoda T. transversa 1 1 Yes 3 No
N. anomala 1 1 Yes 3 No
Phoronida P. harmeri 1 ? ? ? No
Hemichordata S. kowalevskii 1 1 ? 4 No
Echinodermata S. purpuratus 1 1 ? 4 No
Chordata B. floridae 1 ? ? ? No
C. intestinalis 2 1 Yes(1), ?(1) 1(1), 3(1) No
H. sapiens 4 1 Yes 2 No(3), Yes(1)
Table 1.  Distribution and diversity of EGFRs in Metazoa. 1TM means trans-membrane domains and SP 
signal peptide. 2in parenthesis, number of identified genes exhibiting that number of trans-membrane domains, 
signal peptide, cysteine-rich domains and inactive/active TK domains.
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unknown. Accordingly, we also know little about the evolution and functional diversification of this important 
signaling pathway during animal history.
In this study, we use the numerous accessible genomic and transcriptomic datasets to present phylogenetic 
analyses of the two key EGFR signaling pathway components –EGFRs and EGF ligands– in representatives of 
most major animal clades, together with the identification and characterization of two new EGFRs and nine new 
EGF ligands in the planarian S. mediterranea. Our findings indicate that S. mediterranea has a total of six EGFRs 
and nine EGF ligands, which exhibit a wide variety of expression patterns. Silencing of the newly identified EGF 
ligand Smed-egf-6 by RNA interference phenocopies the previously reported role of the EGFR Smed-egfr-525, 
suggesting a mechanistic connection between them. Altogether, our data permit us to hypothesize that the last 
common metazoan ancestor had one EGFR and one probable EGF-like ligand, and that the neuregulin-like type 
of ligands appeared in the last common bilaterian ancestor. Our study indicates that the evolutionary history of 
the EGFR pathway is characterized by frequent independent expansions of an originally minimal set of one EGFR 
and one (Metazoa) or two (Bilateria) EGF ligands. These data may help us to understand how this signaling path-
way has acquired its broad diversity of physiological roles, as observed in extant animals.
Results and Discussion
Distribution and diversification of EGFRs in Metazoa. A thorough investigation of the genomic and 
transcriptomic data available for a wide diversity of animal lineages revealed that the EGFR subfamily of RTKs is 
present in almost all animal groups (Table 1), including ctenophores and sponges32, the two earliest branching ani-
mal clades26. Significant exceptions are cnidarians and placozoans, for which the absence of an EGFR ortholog has 
been previously reported33,34, and the gastrotrich Lepidodermella squamata. In this latter case, further sequencing 
and sampling efforts will be required to confirm this absence. The orthology assignment of all identified EGFR 
sequences was confirmed by a phylogenetic analysis of the tyrosine kinase (TK) domain, including representatives 
of all metazoan RTKs subfamilies and the RTKs of the amoebozoan Acanthamoeba castellanii (Supplementary 
Figure 1). This analysis was corroborated by a further phylogenetic analysis of the whole EGFR sequence (Fig. 1).
Despite particular relationships are not strongly supported in our orthology analysis, the number, distribution 
(Table 1) and general phylogenetic relationships (Fig. 1) of the EGFRs suggest that a single copy of this RTK was 
present in the last common metazoan ancestor, as well as at the base of the three major bilaterian groups: the 
Deuterostomia, the Ecdysozoa and the Spiralia. Subsequent independent expansions occurred in certain bila-
terian lineages, such as xenacoelomorphs, tunicates, vertebrates, platyhelminthes, clitellate annelids, molluscs, 
and bryozoans. While the overall domain architecture of all EGFRs is highly similar (Fig. 1), the number of 
extracellular cysteine rich domains can vary considerably (Table 1). The previous assumption that vertebrate 
and invertebrate EGFRs differ in the number of cysteine rich domains (2 in vertebrate EGFRs; 3 in the EGFRs of 
D. melanogaster and C. elegans)35 is not supported by our data. In fact, the copy number of this extracellular 
Figure 1. Maximum likelihood (ML) phylogenetic tree of representative EGFRs as obtained by RAxML. 
The tree was rooted with the EGFR-related tyrosine kinases SHARK and ZAP-70. The model of protein 
evolution used was LG + G + I. Nodal support was obtained by RAxML 1000 replicates (bootstrap value [BV]) 
and Bayesian posterior probabilities (PP). Both values are shown for key branches. A blue dot at the node 
indicates BV > 95% and PP > 0.95. Fast evolving sequences, such as those of the planarian S. mediterranea, were 
not included in this analysis (for the entire dataset, see Additional file 1: Figure S1). The archetypical domain 
architecture of an EGFR is shown on the left.
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domain seems to oscillate between 2 and 5, and rather than being species-specific, it appears to vary even between 
paralog EGFRs (Table 1). Interestingly, we found EGFR sequences with potentially inactive (or at least highly 
divergent) tyrosine kinase domains in the planarian S. mediterranea and the limpet Lottia gigantea (Table 1) 
(Supplementary Figure 2). This condition is similar to the situation observed in the human Erbb3 receptor36–39, 
and suggests that EGFR duplication in some spiralian lineages has been accompanied by the evolution of alterna-
tive regulation/modulation of EGFR signaling.
The EGFR complement of the planarian S. mediterranea. The re-investigation of the most recent 
transcriptome and genome resources of S. mediterranea40,41 using the newly identified EGFR sequences of the 
early branching polyclad flatworm Prostheceraeus vittatus (this study) as queries42, allowed us to recover two new 
EGFRs, which we named Smed-egfr-4 and Smed-egfr-6. As such, S. mediterranea includes six EGFRs in its genome, 
which is in the range of the other flatworm species that we analyzed: 8 EGFRs in the macrostomid Macrostomum 
lignano, 6 EGFRs in the polyclad P. vittatus, and 3 EGFRs in the parasites Schistosoma mansoni and Echinoccocus 
multilocularis (Table 1). An orthology analysis of the recovered flatworm EGFRs using other spiralian sequences 
as an outgroup (Fig. 2A) revealed that the expansions observed in Macrostomorpha, Polycladida and Neoophora 
(planarians and parasites) occurred independently, and thus there was likely one single EGFR copy in the last 
common platyhelminth ancestor, as in most other spiralian lineages. Importantly, planarian EGFRs group in three 
distinct clades, which we named group A, B, and C (Fig. 2A). The receptor Smed-egfr-1 is the single representative 
of group A (Fig. 2B). Group B includes the receptors Smed-egfr-2, Smed-egfr-3 and Smed-egfr-4, which exhibit 
canonical domain architectures, but a varying number of cysteine rich domains (Fig. 2B). Finally, group C consists 
of the receptors Smed-egfr-5 and Smed-egfr-6, the latter with key amino acid substitutions that may inactivate the 
ATP binding and active sites of the tyrosine kinase domain (Supplementary Figure 2).
Figure 2. Maximum likelihood (ML) phylogenetic tree of flatworm EGFRs as obtained by RAxML.  
(A) The tree was rooted with the EGFRs of representative spiralian taxa. The model of protein evolution used 
was LG + G + I. Nodal support was obtained by RAxML 550 replicates (bootstrap value [BV]) and Bayesian 
posterior probabilities (PP). Both values are shown in key branches. A blue dot in the node indicates BV > 95% 
and PP > 0.95. Planarian sequences are highlighted in red. (B) Schematic representation of the domain 
architecture of each S. mediterranea EGFR, drawn to scale.
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Previous studies characterized the expression and function of the S. mediterranea EGFRs Smed-egfr-1, 
Smed-egfr-2, Smed-egfr-3 and Smed-egfr-5 in adult worms23,25. The receptor Smed-egfr-1 is expressed in the gut, 
pharynx, and eye pigment cells (Fig. 3A), and is required for the proper regeneration and homeostasis of the 
eyes, pharynx and gut (Fig. 3B)23,31. The paralog Smed-egfr-2 is expressed in the gut (Fig. 3A), and no apparent 
phenotype is observed after silencing23. The receptor Smed-egfr-3 is detected in the neoblast, pharynx and the 
cephalic ganglia (Fig. 3A) and is required for the proper growth of the blastema during regeneration, probably by 
regulating cell differentiation (Fig. 3B)23,24. Finally, Smed-egfr-5 is expressed in the excretory system (Fig. 3A) and 
is required for its proper regeneration (Fig. 3B)25. We performed whole mount in situ hybridization experiments 
to characterize the expression domains of the newly identified Smed-egfr-4 and Smed-egfr-6 genes. The receptor 
Smed-egfr-4 was mainly expressed in the central nervous system and pharynx, and weakly in the mesenchyme 
(Fig. 3A). The paralog Smed-egfr-6 was expressed in the pharynx and in a discrete pattern throughout the body 
(Fig. 3A). The silencing by RNAi of either Smed-egfr-4 or Smed-egfr-6 gave no perceivable external phenotypes 
(data not shown). Altogether, our findings support that the expansion of EGFRs that occurred in the lineages 
leading to S. mediterranea has been accompanied by a molecular, transcriptional and functional diversification of 
the different paralogs. However, further expression and functional analysis in other platyhelminthes and spiralian 
lineages are essential to better understand the ancestral role of the EGFR in these organisms.
Distribution of EGF ligands in Metazoa. The evolution of EGF ligands has been mostly studied in ver-
tebrates, C. elegans, and D. melanogaster17,43–45. Because the only common feature to all ligands is the presence 
of an EGF domain, which is a motif present in a tremendous diversity of proteins17, we designed a conserva-
tive approach to identify new putative EGF ligands. Candidate genes had to be full length (see Material and 
Methods for the very few exceptions to this criteria), with only one EGF motif, and with domain architectures 
consistent with the structures of already known EGF ligands17. Our in silico searches reported 75 new potential 
Figure 3. Expression patterns of planarian EGFRs. (A) Whole-mount in situ hybridizations of all planarian 
EGFRs on intact adult specimens of S. mediterranea, grouped according to their phylogenetic relationship. See 
main text for details of the expression patterns. (B) Schematic summary of the expression patterns of planarian 
EGFRs and the phenotype observed after their silencing by dsRNA injection, a dash indicates no phenotype was 
observed (see references for further details). In (A), anterior is to the left. ph: pharynx. Scale bars: 500 μ m in all 
panels.
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EGF ligands (Table 2), in addition to those already described for Homo sapiens, C. elegans, D. melanogaster 
and Tribolium castaneum. Consistent with the absence of an EGFR, we did not recover any putative EGF lig-
ands in the cnidarian databases analyzed. An analysis of domain compositions revealed two basic architectures: 
the EGF-type of ligands, with only an EGF domain and a varying number of transmembrane regions (from 
zero, in soluble candidates, to two); and the neuregulin-type (NRG-type) of ligands, which showed an EGF 
domain combined with an immunoglobulin I-set domain and a transmembrane region (Supplementary Figure 
3). Representatives of the first group are the H. sapiens EGF ligands egf, hb-egf, TGFα, areg, epr, btc, and epigen, 
lin-3 from C. elegans, and the D. melanogaster ligands gurken, keren and spitz. Examples of the NRG-type of 
EGF ligands are the human nrg-1 and nrg-2, and the D. melanogaster gene vein. While we were able to recover 
putative ligands of the EGF-type in almost all animal lineages analyzed –with the exception of the sea urchin 
Strongylocentrotus purpuratus and the phoronid Phoronopsis harmerii–, NRG-type ligands were only identified 
in bilaterian groups (Table 2).
Phylogenetic studies of the EGF ligands tend to analyze vertebrate and invertebrate sequences separately43, 
to avoid artifacts associated with the low phylogenetic signal obtained from the EGF domain. Therefore, we first 
performed a sequence-similarity-based clustering analysis of all retrieved putative EGF ligands, with the aim 
of supporting our domain-based classification (Supplementary Figure 4). NRG-type ligands clustered together, 
which supported considering them a bona fide subtype, but most EGF-type ligands were highly dispersed and 
weakly interconnected. The failure to recover a well-defined cluster of EGF-type ligands is another sign of the low 
phylogenetic signal of EGF ligands. This is most likely caused by the extreme variability in the protein structure 
of these genes, and the fact that the only common region –the EGF motif– is also very variable, beyond the few 
conserved amino acids that are invariable among all species (e.g. the six conserved cysteines17). Following the 




Ctenophora M. leidyi 1 1 0
Porifera A. queenslandica 1 1 0
Placozoa T. adhaerens 1 1 0
Cnidaria N. vectensis 0 – –
H. magnipapillata 0 – –
Xenacoelomorpha X. bocki 2 1 1
M. stichopi 5 4 1
I. pulchra 5 2 3
C. macropyga 2 0 2
Priapulida P. caudatus 1 1 0
H. spinulosus 2 1 1
Nematoda C. elegans 1 1 0
Arthropoda T. castaneum 1 1 0
D. melanogaster 4 3 1
Gastrotricha L. squamata 2 2 0
Platyhelminthes M. lignano 2 1 1
P. vittatus 9 7 2
S. mediterranea 9 8 1
S. mansoni 1 0 1
E. multilocularis 2 1 1
Mollusca L. gigantea 1 1 0
C. gigas 1 0 1
Annelida O. fusiformis 3 2 1
C. teleta 4 4 0
H. robusta 4 3 1
Nemertea L. ruber 4 3 1
Bryozoa M. membranacea 2 1 1
Brachiopoda T. transversa 1 1 0
N. anomala 1 1 0
Hemichordata S. kowalevskii 2 1 1
Echinodermata S. purpuratus 1 0 1
Chordata B. floridae 5 4 1
C. intestinalis 2 2 0
H. sapiens 11 7 4
Table 2.  Distribution and diversity of EGF ligands in Metazoa.
www.nature.com/scientificreports/
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separately (Fig. 4A,B) (Supplementary Figures 5 and 6). In line with previous reports43 and our findings after 
the sequence-similarity analysis, we could not resolve the deepest relationships between all metazoan EGF-type 
putative ligands. Regarding the NRG-type, we could tentatively assign orthology relationships between the two 
ambulacrarian NRGs, the two ecdysozoan NRGs, and the four human NRGs, which confirmed a previous analy-
sis of vertebrate EGF ligands43. All things considered, the distribution of EGF ligands, the domain architecture of 
the diversity of candidate genes, and the clustering and phylogenetic analyses, support dividing the EGF ligands 
into two separate classes: the EGF-type and the NRG-type. The presence of the EGF-type in the ctenophore 
Mnemiopsis leidyi, the sponge Amphimedon queenslandica and the placozoan Trichoplax adhaerens indicates 
that this was likely the ancestral EGFR ligand. However, further biochemical analyses are needed to confirm 
that this putative EGF ligand actually binds the EGFRs present in the ctenophore and the sponge, and thus the 
existence of a truly functional EGFR signaling pathway in these early branching animal lineages. Consistent with 
its presence in xenacoelomorphs and most other bilaterian groups, the NRG-type appears to be an innovation 
of Bilateria.
The EGF ligand complement of S. mediterranea. Our search for EGF ligands in the genome40 and pub-
licly available transcriptomes of S. mediterranea41 reported nine candidate genes (Table 2), including the previ-
ously described Smed-epiregulin-130 and the recently identified Smed-nrg-131. Eight of these were of the EGF-type, 
and only one was of the NRG-type. Smed-epiregulin-1 belongs to the EGF-type, and given the fact that the gene 
epiregulin is a vertebrate-specific paralog of an ancestral EGF-like gene44, we renamed this planarian candidate 
as Smed-egf-1. We named the rest of the planarian putative EGF-type ligands consecutively, from Smed-egf-2 
to Smed-egf-8, and the only NRG-type ligand as Smed-nrg-131. The phylogenetic analysis of spiralian putative 
Figure 4. Maximum likelihood (ML) phylogenetic tree of the putative EGF ligands as obtained by RAxML. 
(A) Unrooted tree of the EGF-type of EGF ligands, using the Whelan and Goldman (WAG) + G model of 
protein evolution. Nodal support was obtained by RAxML 500 replicates (bootstrap value [BV]) and Bayesian 
posterior probabilities (PP). (B) Unrooted tree of the NRG-type of EGF ligands, using the LG + G model 
of protein evolution. Nodal support was obtained by RAxML 1000 replicates (BV) and Bayesian posterior 
probabilities (PP). Fast evolving sequences, such as those of the planarian S. mediterranea, were not included 
in these analyses (for the entire dataset, see Additional files 4, 5: Figure S4, S5). The archetypal domain 
architectures of the EGF-type and NRG-type of ligands are shown on the left.
www.nature.com/scientificreports/
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EGF-type ligands did not recover monophyly of the platyhelminth sequences (Fig. 5A), most probably due to the 
low phylogenetic signal of the EGF domain. However, this analysis suggested three planarian-specific clusters 
(Fig. 5A). The first group includes from Smed-egf-1 to Smed-egf-5, which are all characterized by presenting the 
EGF domain upstream of the transmembrane region. The second cluster consists of Smed-egf-6 and Smed-egf-7, 
and both are secreted ligands without transmembrane domain. Finally, Smed-egf-8 branches independently from 
other planarian EGF ligands in our orthology analyses, and has a domain architecture similar to the group of 
Smed-egf-1 to Smed-egf-5. As observed in the current genomic version40, the presence of introns in all the identi-
fied ligands and the six EGFRs suggests that the expansion of these two gene families did not occur by retroposi-
tion, but rather by gene duplications.
We next analyzed the expression of the identified putative EGF ligands in adult intact specimens of S. med-
iterranea (Fig. 6A). The ligands Smed-egf-1 and Smed-egf-2 were expressed in the gut, and Smed-egf-3 tran-
scripts localized to the pharynx and in scattered mesenchymal cells around it, a pattern reminiscent of other 
pharynx-related genes, such as foxA46,47. Expression of Smed-egf-4 was detected in the pharynx, the mesenchyme 
around it, and the central nervous system (Fig. 6A), while Smed-egf-5 was expressed in the pharynx and esoph-
agus (Fig. 6A). The putative ligand Smed-egf-6 was mainly detected in isolated cells of the lateral margin of the 
planarian, at the boundary between the dorsal and the ventral epidermis. Notably, the expression was stronger 
and the number of cells greater in the margin of the head, where Smed-egf-6 also localized to isolated cells of the 
anterior dorsal midline (Fig. 6A; inset). The EGF-type putative ligand Smed-egf-7 was expressed in the brain –
strongly in the posterior region of the cephalic ganglia–, pharynx and the mesenchyme around it (Fig. 6A), and 
Smed-egf-8 was detected in the mesenchyme and pharynx. Finally, Smed-nrg-1 was expressed in the pharynx and 
mesenchyme (Fig. 6A). Altogether, these findings show that the nine putative EGF ligands of S. mediterranea 
Figure 5. Maximum likelihood (ML) phylogenetic tree of the putative flatworm EGF ligands as obtained 
by RAxML. (A) Unrooted tree of the EGF-type of EGF ligands, using the Whelan and Goldman (WAG) + G 
model of protein evolution. Nodal support was obtained by RAxML 900 replicates (bootstrap value [BV]) and 
Bayesian posterior probabilities (PP). (B) Unrooted tree of the NRG-type of EGF ligands, using the LG + G 
model of protein evolution. Nodal support was obtained by RAxML 450 replicates (BV) and Bayesian posterior 
probabilities (PP). The domain architectures of each subgroup of planarian EGF ligands are shown on the right. 
Planarian sequences are highlighted in red.
www.nature.com/scientificreports/
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exhibit a broad diversity of expression patterns, relating mostly to pharyngeal and gut tissues as well as the nerv-
ous system (Fig. 6B).
To gain a better understanding of the function of these candidate ligands, and their potential relationships 
with the described EGFRs, we performed single RNAi gene silencing by double stranded RNA (dsRNA) injec-
tions and assessed the consequences during anterior and posterior regeneration. Out of the eight putative 
EGF-type ligands, we only observed an apparent phenotype after Smed-egf-6 RNAi, which could indicate some 
level of functional redundancy between these ligands. However, we cannot discard the possibility that those 
for which we did not observe any phenotype could be involved in more cell-specific roles that we could not 
discriminate at the gross morphological level. Silencing of Smed-egf-6 did not affect the regeneration of missing 
structures, but rather, produced edemas (Fig. 7A), a phenotype remarkably similar to the one observed after 
Smed-egfr-5 RNAi25. To determine if the swollen phenotype was caused by defects in the excretory system, as 
described for Smed-egfr-5(RNAi) animals, we analyzed the expression of the specific protonephridial marker 
carbonic anhydrase (CAVII-1)25. As expected, Smed-egf-6(RNAi) regenerating animals showed a reduced num-
ber of, and aberrant, protonephridial tubules (Fig. 7A), suggesting that the edemas were caused by an abnormal 
regeneration of this organ system. We further confirmed these results during adult homeostasis in intact animals 
(Fig. 7B). These findings suggest that Smed-egf-6 could act through Smed-egfr-5 to regulate planarian excretory 
Figure 6. Planarian epidermal growth factors ligands. (A) Whole-mount in situ hybridizations of all 
putative planarian EGF ligands on intact adult specimens of S. mediterranea, grouped according to their 
subtype and phylogenetic relationships. See main text for details of the expression patterns. In egf-4, the yellow 
arrowheads indicate the central nervous system. In egf-6, the yellow arrowheads indicate expression in the 
body margin, and the inset (region delimited by the yellow rectangle) is a magnification of the expression in the 
dorsal anterior midline. Faint signal in the pharynx and central body region in egf-6 is background staining. 
In egf-7, the inset is a magnification showing the expression in the brain. (B) Schematic summary of the 
expression patterns of the planarian putative EGF ligands and the phenotype observed after their silencing by 
dsRNA injection (see references and main text for further details). In (A), anterior is to the left. ph: pharynx. 
Scale bars: 500 μ m in all panels.
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system regeneration and homeostasis. We have also recently reported that silencing Smed-nrg-1 causes an abnor-
mal regeneration of the eyes, gut and pharynx31, suggesting that this putative ligand signals via the Smed-egfr-1 
receptor. Although we have only observed an apparent phenotype for two of the nine putative ligands, their roles 
during regeneration and homeostasis are consistent with those previously assigned to planarian EGFRs. We pro-
pose that this concurrence validates our bioinformatic approach for ligand identification.
In summary, the demonstrable relevance of the EGFR pathway in the fields of biomedicine, cancer and 
developmental biology3 contrasts with our limited understanding of the evolution and functional diver-
sification of this pathway in the animal tree of life. Our broad genomic survey of representatives of 19 dif-
ferent major animal clades suggests that the EGFR pathway probably evolved within the metazoan stem 
lineage (Fig. 8)32 and comprised an EGF receptor and a single putative EGF-like ligand, as observed in 
extant ctenophores and sponges. The EGFR pathway appears to be missing from placozoan and cnidar-
ian lineages, while the presence of a neuregulin-like putative ligand in the vast majority of bilaterian spe-
cies analyzed indicate that this new type of EGFR ligand appeared together with the Bilateria (Fig. 8). 
Subsequently, the EGFR and/or the EGF ligands have frequently become expanded in many bilaterian lin-
eages, and new modes of signaling modulation (e.g. via inactive Tyr kinase domains) have appeared 
(Fig. 8). The planarian S. mediterranea (Platyhelminthes) is a prototype of these evolutionary events, 
because it exhibits an EGFR pathway with 6 EGF receptors –including one putative inactive EGFR–, and 9 
EGF ligands –1 neuregulin-like and 8 EGF-like. Gene expression and functional analyses demonstrate 
that these components are detected in most of the differentiated tissues of the planarian (Figs 3 and 6)23,25, 
and control the regeneration and homeostasis of different organs, tissues, and body regions of the animal (Fig. 7), 
probably by regulating cell differentiation23–25,31. Altogether, our findings deliver an expanded and detailed 
evolutionary framework that makes a significant contribution towards our understanding of the molecular and 
functional diversification of the EGFR pathway in animals, and which will improve future comparisons between 
emerging biomedical systems, such as planarians, and better-established classical model organisms.
Figure 7. Role of Smed-egf-6 during adult planarian regeneration and homeostasis. Regenerating (A) and 
intact (B) animals were injected on three consecutive days, and fixed two weeks after the last injection. Treated 
animals form edemas (yellow arrowheads) during both regeneration (A) and homeostasis (B). Whole-mount in 
situ hybridization of the protonephridial marker Smed-CAVII-1 in Smed-egf-6(RNAi) animals demonstrates a 
decrease in the number of protonephridial tubules compared to control animals. Numbers in each panel refer to 
the frequency of the phenotype. In all panels, anterior is to the top. Scale bars: 500 μ m in all panels.
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Methods
Database searching and phylogenetic analyses. All potential EGFRs and EGF ligands were identified 
by BLAST and HMMER searches against completed genome/transcriptome databases publicly available or that 
are being generated in our laboratories (Supplementary Material). Searches were conducted with default parame-
ters and an inclusive E-value of 0.05. For the EGFRs, only sequences including the tyrosine kinase domain (com-
plete or partial) were considered. Regarding the EGF ligands, only full-length sequences with coherent domain 
architectures were used in subsequent analyses. The only exceptions for this rule were the previously described 
planarian ligand (Smed-epiregulin-1)30, which lacks the N-terminal region, as well as the newly identified NRG-
type ligand of X. bockii and EGF-type ligands of P. caudatus, H. spinulosus and S. kowalevskii, which all lack 
the very C-terminal end of the protein but give high BLAST and HMMER similarities to other described EGF 
ligands. The retrieved sequences were aligned using MAFFT v748. Poorly aligned regions of the multiple protein 
alignment of EGFRs were removed with Gblocks49 using the least stringent parameters. Only the EGF domain 
of the candidate EGF ligands was used for phylogenetic analyses. In the case of the NRG-type ligands, also the 
immunoglobulin domain was included in the analyses. Maximum likelihood (ML) phylogenetic analyses were 
conducted with RAxML v850 with the autoMRE option on to calculate the bootstrap support values. Bayesian 
inference analyses were performed with MrBayes v351 using two parallel runs, sampling every 100 generations. 
Bayesian posterior probabilities were used for assessing the statistical support of each bipartition.The domain 
architecture of each identified sequence was analyzed using InterProScan 552 and SignalP 4.1 53, and manually 
verified when automatic predictions where dubious. The domain information was used to assess the reliability of 
each sequence of the initial dataset and to help define protein families according to their architectural coherence.
Figure 8. Summary scenario for the evolution of the EGFR signaling pathway in Metazoa. On the right, 
distribution of the identified EGFRs (yellow rectangles) and putative EGF ligands (EGF-type, green dots; NRG-
type, purple dots) in the analyzed animal lineages is shown. A triplicate symbol indicates that this particular 
type of protein (EGFR, EGF-type and NRG-type of ligands) appears expanded in this lineage. Our findings 
indicate that the last common metazoan ancestor had one EGFR and one putative EGF-type ligand. The NRG-
type of EGF ligand is Bilateria-specific. The ancestral bilaterian set of one EGFR, one EGF-type and one NRG-
type of ligands seems to be retained in the last common ancestors of both Deuterostomia and Protostomia. 
Subsequently, particular bilaterian lineages have experienced expansions of one or more of these basic EGFR 
signaling components. Additionally, vertebrates, the limpet L. gigantea and the planarian S. mediterranea have 
an EGFR with an inactive tyrosine kinase domain, which suggests the independent evolution of alternative 
regulatory mechanisms of this signaling pathway. Tree topology based on26,59,60.
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Clustering analysis of the potential EGF ligands. A sequence-similarity-based (PSI-BLAST P-values) 
clustering approach to analyze the global phylogenetic relationships of the potential EGF ligands was performed 
with CLANS54. A cutting P-value of 1e-15 was applied.
Planarian culture. Asexual S. mediterranea from the BCN-10 clonal line were maintained in artificial 
water55. Animals were fed with veal liver and starved for at least 1 week before conducting any experiment.
Gene cloning and whole-mount in situ hybridization. The newly identified planarian EGFRs and 
putative EGF ligands were isolated by gene-specific PCR and cloned into the pGEM-T vector (Promega). 
Whole-mount in situ hybridization experiments were performed as previously described56,57. All samples 
were observed through a Leica MZ16F stereomicroscope and images were captured with a ProgResC3 camera 
(Jenoptik). Images were processed with Photoshop CS6 (Adobe) and figures were mounted in Illustrator CS6 
(Adobe). Brightness/contrast and color balance adjustments were applied to the whole image, not parts.
RNA interference. Silencing by RNAi was performed as described elsewhere58. Control animals were 
injected with double-stranded RNA for green fluorescent protein (GFP). In Smed-egf-6(RNAi) experiments, all 
animals received one round of injection (each consisting of three injections on consecutive days). For experi-
ments on regenerating animals, planarians were amputated 1 day after the last injection and allowed to regenerate 
14 days before fixation. For homeostatic experiments dsRNA-injected animals were kept in starvation for 2 weeks 
before fixation. In the RNAi experiments of the other components of the EGFR pathway in S. mediterranea identi-
fied in this study, all animals received two rounds of injections (each consisting of three injections on consecutive 
days) separated by 3–4 days and were amputated 1 day after both rounds of injection. Since no phenotype was 
observed during regeneration with these genes, we did not proceed with homeostatic RNAi experiments.
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